Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
Study of Tegavivint, a Transducin Beta-like Protein 1 (TBL1) Inhibitor, With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
The goal of this clinical trial is to define the maximum tolerated dose (MTD) and/or Recommended phase 2 dose (RP2D) of Tegavivint in combination with Gemcitab…
Osteosarcoma RecurrentOsteosarcoma in ChildrenRelapsed Osteosarcoma+1 more
Emory UniversityNCT07144254
Phase 1
DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma
The purpose of this study is to determine the feasibility of administering DFMO to patients with relapsed Ewing sarcoma and osteosarcoma who have completed all…
Osteosarcoma RecurrentEwing's Tumor Recurrent
Montefiore Medical CenterNCT06892678